Form 4 Tracker
Nurix Therapeutics, Inc.
NRIX

42 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 26, 2024Aug 26 8:24 PMCHRISTINE RING
Proposed Sale
9,870$24.02$237.1K—

View →

Aug 1, 2025—JOHANNES VAN HOUTE
Proposed Sale
5,402$11.26$60.8K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 15, 2026May 15 9:37 PMJulia P GregoryDirector
Grant/Award
31,250$15.8631,250(D)

View →

Apr 30, 2026Apr 30 9:38 PMHoute Hans VanChief Financial Officer
Option Exercise
8,608—22,867(D)

View →

Apr 30, 2026Apr 30 9:37 PMChristine RingChief Legal Officer
Option Exercise
8,608—22,867(D)

View →

Apr 30, 2026Apr 30 9:35 PMGwenn HansenChief Scientific Officer
Option Exercise
8,608—22,867(D)

View →

Feb 10, 2026Feb 10 11:09 PMHoute Hans VanChief Financial Officer
Grant/Award
136,625$16.4542,875(D)

View →

Feb 10, 2026Feb 10 10:55 PMChristine RingChief Legal Officer
Grant/Award
136,625$16.4542,875(D)

View →

Feb 10, 2026Feb 10 10:50 PMGwenn HansenChief Scientific Officer
Grant/Award
136,625$16.4542,875(D)

View →

Feb 10, 2026Feb 10 10:43 PMSANDS ARTHUR TDirector, President, CEO
Grant/Award
562,500$16.45562,500(D)

View →

Feb 3, 2026Feb 4 2:12 AMGwenn HansenChief Scientific Officer
Option Exercise
31,333$0.840(D)

View →

Jan 30, 2026Jan 31 1:39 AMHoute Hans VanChief Financial Officer
Option Exercise
11,496—25,725(D)

View →

Jan 30, 2026Jan 31 1:38 AMChristine RingChief Legal Officer
Option Exercise
10,534—25,725(D)

View →

Jan 30, 2026Jan 31 1:36 AMGwenn HansenChief Scientific Officer
Option Exercise
11,816—25,725(D)

View →

Jan 20, 2026Jan 21 12:57 AMChristine RingChief Legal Officer
Option Exercise
3,760$1.868,643(D)

View →

← Previous

Page 2 of 2